Figure 3From: The changing patterns of dispensing branded and generic drugs for the treatment of gastroesophageal reflux disease between 2006 and 2011 in Japan: a retrospective cohort studyVolume and value shares of branded and generic drugs by drug classes and molecules. (1a) overall volume share, (1b) overall value share, (2a) volume share by drug class, (2b) value share by drug class, (3a) volume share of PPIs, (3b) value share of PPIs, (3c) volume share of H2RAs, (3d) value share of H2RAs.Back to article page